View in EDS HTML Full Text PDF Full Text

A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer.

Saved in:
Bibliographic Details
Title: A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer.
Authors: Sebastian, Martin1,2 (AUTHOR) martin.sebastian@kgu.de, Schröder, Andreas3,4 (AUTHOR), Scheel, Birgit3 (AUTHOR), Hong, Henoch S.3,4 (AUTHOR), Muth, Anke3 (AUTHOR), von Boehmer, Lotta5,6 (AUTHOR), Zippelius, Alfred7 (AUTHOR), Mayer, Frank8,9 (AUTHOR), Reck, Martin10 (AUTHOR), Atanackovic, Djordje11,12 (AUTHOR), Thomas, Michael13 (AUTHOR), Schneller, Folker14 (AUTHOR), Stöhlmacher, Jan15,16 (AUTHOR), Bernhard, Helga17 (AUTHOR), Gröschel, Andreas18,19 (AUTHOR), Lander, Thomas3 (AUTHOR), Probst, Jochen3,20 (AUTHOR), Strack, Tanja3 (AUTHOR), Wiegand, Volker3 (AUTHOR), Gnad-Vogt, Ulrike3 (AUTHOR)
Source: Cancer Immunology, Immunotherapy. May2019, Vol. 68 Issue 5, p799-812. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:03407004
DOI:10.1007/s00262-019-02315-x